What an implant claim needs behind it

An ASC implant claim is usually paid on four things: a HCPCS code the payer accepts as an implant, an operative note recording the device, a vendor invoice showing cost and units, and, in one state, a signed certification of actual cost. Which of the four is mandatory, and whether it travels with the claim, is set by the payer rather than by any general standard.

Six questions about ASC implant billing answers the documentation question in a few paragraphs. This is the long version, read out of the rules that set the requirement: the federal condition for coverage governing ASC medical records, the Medicare ASC claims manual, two commercial payer reimbursement policies, and three workers’ compensation fee schedules.

Those rules govern different claims, and none of them governs your commercial contract. They are useful here for the same reason the carve-out definitions were: they ask for different documents, and every difference marks something a contract either settles or hands to the payer.

Does the federal medical record rule require the device?

No. It does not mention implants at all.

42 CFR 416.47 is the condition for coverage on medical records, and it is the floor every Medicare-certified ASC has to meet. It requires the ASC to maintain “complete, comprehensive, and accurate medical records to ensure adequate patient care,” and lists what each record must contain: patient identification, significant medical history and results of physical examination, pre-operative diagnostic studies if performed, “findings and techniques of the operation, including a pathologist’s report on all tissues removed during surgery,” allergies and abnormal drug reactions, entries related to anesthesia administration, documentation of properly executed informed consent, and discharge diagnosis.

Read the operative item again. It covers findings, techniques and tissue removed. The device left in the patient is not one of the eight items, and the section asks for no catalog number, no lot number and no cost.

That is not a drafting error. The condition is about patient care, and device detail reaches the chart for clinical reasons and, as the sections below show, because individual payers ask for it. It does not get there because 416.47 requires it. The rule that governs the chart is not the rule that gets the implant paid, and the facts a payer wants were never the facts the chart was built to carry.

What does Medicare need for an implant it pays separately?

Almost nothing, because there is almost never a separate line. CMS packages implantable devices without pass-through status into the ASC payment for the covered surgical procedure, which is the subject of what the CMS manual actually says about ASC implant billing.

Two situations survive the packaging, and both are priced off a document rather than a published rate.

The first is pass-through devices, which carry ASC payment indicator J7. Chapter 14 of the Medicare Claims Processing Manual puts them in a small group of contractor-priced services: pass-through devices “are paid separately and are contractor-priced based on acquisition cost or invoice.”

The second is a device the center did not pay full price for. Section 40.8, revised effective July 1, 2026, requires modifier FB on the procedure code when a specified device is furnished without cost or with full credit, and modifier FC when the center receives a partial credit of 50 percent or more of the device’s cost, on procedures on the FC list. A single procedure code should not carry both. For separately payable pass-through devices the modifiers do not apply, and instead “ASCs should report the amount of the credit along with the invoice price of the separately payable device on the claim. The line-item charge for the separately payable device must reflect the amount of the credit received.”

So Medicare’s separate-payment path runs on acquisition cost and credit memos. Neither of those is a clinical fact, and the Medicare post covers why the modifier decision arrives on the manufacturer’s paperwork rather than in the operative note.

What does a commercial payer ask for?

Two published policies, which is two payers rather than the market. Each governs only its own claims, and each says a provider contract can override it.

UnitedHealthcare’s commercial facility policy on devices, implants and skin substitutes, policy number 2026R5019F, applies to UB04 claims from “all network and non-network outpatient facility claims, Ambulatory Surgical Centers (ASC), Outpatient Surgical Centers (OSC).” Three requirements in it decide whether an implant line survives.

• A HCPCS code that meets the FDA definition. “When a revenue code representing implants is submitted, a HCPCS code which meets the FDA definition of an implant must be reported for outpatient services. If a HCPCS code is not submitted or if the HCPCS code submitted does not match the FDA definition of an implant, the claim line with the implant revenue code will not be reimbursed.” The policy’s own Q and A is blunter: a HCPCS code must accompany revenue code 0278 on an outpatient claim, or “the line item will be denied.”
• The device and the procedure on one claim. For procedures the policy treats as device dependent, “the device or implant must be submitted with the same date of service and on the same claim as the procedure. A device or implant dependent procedure will be denied if reported without an applicable device or implant on the same claim and date of service.” Which procedures those are is defined in the CMS Integrated Outpatient Code Editor HCPCS data file, not in the policy text.
• Credits, coded. A device obtained at no cost or reduced cost “must be submitted with the appropriate condition code, value code, and modifier”: condition codes 49, 50 or 53, value code FD, and modifier FB or FC.

Blue Cross and Blue Shield of New Mexico’s implant, device and tissue policy RP007, effective August 28, 2026, is the one that asks for the invoice, and it is specific about what the invoice has to show. Note the qualifiers, which are the policy’s own.

• “If separately reimbursable, billed charges for revenue code 0278 may require a vendor’s invoice to support the implants used that correspond to the services rendered, unless otherwise agreed upon.”
• “These units must be clearly indicated on the vendor invoices submitted with the claim. If the units do not match or are not noted, the revenue code 0278 will be denied, unless otherwise agreed upon.”
• If implants were bought in bulk, “the units that apply to the claim billed must be noted on the invoice or the revenue code 0278 will be denied, unless otherwise agreed upon.”
• The plan “reserves the right to request supporting documentation,” and it does not reimburse implants that were “presumed contaminated, considered a waste, and/or were not implanted in the member,” listing items opened but not used, items opened by mistake, a surgeon’s change of mind, equipment failure and case cancellation.

Sit with the units requirement, because it is the most operational sentence in either policy. It asks the invoice and the claim to agree on a number, and on a bulk invoice it asks the facility to note on the invoice which units belong to this case. Read plainly, that is an annotation someone at the facility adds after the invoice arrives.

What does a workers’ comp payer ask for?

Three fee schedules, all of which pay implants off the invoice, and all of which say so in their own words.

Federal, through OWCP. “Implants must be billed on a separate line using the appropriate HCPCS code.” Where the fee schedule sets no maximum, OWCP “will pay acquisition cost for implants when the bill is accompanied by a copy of the original invoice clearly showing invoice cost less applicable discounts.” Its acquisition cost policy adds the record-keeping: wholesale invoices for all devices “must be retained in the provider’s office files for a minimum of three years,” a hard copy goes in “when an individual device or supply costs $150.00 or more, or upon request,” and payment “may be delayed if this information is not submitted.”

Illinois. Implants under revenue codes 0276 and 0278 “shall be reimbursed at 25% above the net manufacturer’s invoice price less rebates, plus actual reasonable and customary shipping charges.” The invoice is not supporting material here, it is the price itself. The rule also lets the implant charge arrive by several routes: with the facility’s other charges, on a separate claim form, or from the distributor or the manufacturer.

Texas. The strictest documentation requirement of the three, and the most interesting one. A facility requesting separate implantable reimbursement must bill on the Medicare-specific billing form for ASCs and “include with the billing a certification that the amount billed represents the actual cost (net amount, exclusive of rebates and discounts) for the implantable.” The certification has to carry the sentence “I hereby certify under penalty of law that the following is the true and correct actual cost to the best of my knowledge,” signed by “an authorized representative of the facility or surgical implant provider who has personal knowledge of the cost of the implantable and any rebates or discounts.” The carrier may then audit the certified amount, or test it in medical dispute resolution.

Texas is worth reading twice because of what it asks for rather than how strict it is. It does not ask for a number looked up on a claim form. It asks for a signature from someone with personal knowledge of what the implant cost, net of rebates and discounts.

What each rule wants, side by side

What has to be behind an implant line, by source

Source	Invoice with the claim	What it has to show	If it is missing
Medicare, ASC pass-through devices only	Priced on acquisition cost or invoice, by the contractor	Acquisition cost, and the amount of any credit received	Implants without pass-through status are packaged, so there is no separate line to document
UnitedHealthcare 2026R5019F	Not required by the policy	A HCPCS code meeting the FDA implant definition, on the same claim and date as the procedure	The implant line is not reimbursed, and a device-dependent procedure is denied
BCBS of New Mexico RP007	May be required, unless otherwise agreed	Units clearly indicated and matching the claim, identified per case on a bulk invoice	Revenue code 0278 is denied, unless otherwise agreed
OWCP, federal workers’ comp	Hard copy at $150.00 or more, or on request	Invoice cost less applicable discounts; invoices kept three years	Payment may be delayed
Illinois workers’ comp	The invoice price is the basis of payment	Net manufacturer’s invoice price less rebates, plus shipping	Not addressed in the section
Texas workers’ comp	A signed certification of actual cost goes with the billing	Actual cost net of rebates and discounts, certified under penalty of law	Separate implantable reimbursement is conditioned on it

Why ASC implant documentation requirements span three systems

Put the six sources together and they ask for three facts about one screw.

That it was used, which the clinical record holds. What it cost and how many units, which the vendor invoice holds, and the vendor invoice is in accounts payable. That both of those appear correctly on the claim, which is billing’s work. Each of the three is accurate about its own fact. Checking it against the other two is a fourth job, and it is not the job any of the three was built to do.

This is also why an edit on the claim cannot close the question. UnitedHealthcare’s device-dependent rule is a real check and it works: a paired procedure submitted without its device line comes back denied, which is a loud failure. But it compares the claim to a code list. A claim edit can confirm that a claim is internally consistent. It cannot confirm that the implant on this month’s invoice reached a claim at all.

The federal audit data says which of the two failure modes actually costs ASCs money.

That is Medicare data about Medicare claims, and Medicare is the one payer that mostly does not pay implants separately. Read it as a statement about where claims fail rather than as a figure about implants. Nearly everything else published about implant reimbursement comes from companies that sell implant reimbursement services, this site included. This number is produced by the agency doing the paying, about its own claims.

What to have behind every implant line

Drawn from the sources above, with the last item marked as ours because no rule above asks for it.

1. A HCPCS code that meets the payer’s definition of an implant, on the same claim and the same date of service as the procedure.
2. The operative note recording the device, since the medical record condition requires findings and techniques of the operation, and payers reserve the right to request records.
3. The vendor invoice for that device, with the units that belong to this case identified on it.
4. Cost stated net of rebates and discounts, with shipping and tax handled the way your contract says. Where the contract is silent on those, see what an ASC implant carve-out has to define.
5. Any credit received on the device, reported the way that payer requires.
6. Evidence the device was implanted in the patient, rather than opened and discarded.
7. Ours, not theirs: a monthly comparison of every implant on the vendor invoices against the claims that went out. Nothing above asks for it, and it is the only one of the seven that finds an implant line that was never created.

Where Bill-Back fits

Item seven is the whole product, so treat this section as the vendor pitch it is.

Bill-Back reads three documents a center already has: the monthly case log export from the PMS, the vendor invoice PDFs, and the Paid Claims Report, which shows what payers have already paid the center and at what price. Your file is read in your browser, and only what the audit needs is sent: procedure month, payer, CPT code, procedure description, surgeon name, and supply notes, plus a hashed case reference if you map one. Supply notes are sent as the nurse wrote them, because the device description and catalog number are what the audit matches on. Everything sent is handled under a signed BAA.

Each supply note is matched to a vendor catalog number and priced at your contracted rate. Then someone on your side clears anything already on a claim, which is the step that separates matched value from recoverable dollars. What survives becomes a payer-ready Recoup Packet: the corrected claim, the reimbursement basis quoted from your own contract, and the matched invoice line as Exhibit A, for your own biller to submit. A corrected claim inside the filing window, not an appeal.

Commercial payers only, for the reason in the Medicare section. Stryker and Arthrex invoices are supported today, everything else goes through manual review, and new invoice layouts are added as centers send their invoices. Free to audit, and you only pay when the payer pays.

You can estimate what that seam is worth at your case volume in about thirty seconds, or start a free audit against a month of your own files.

Sources

Every requirement above traces to one of these.

Government and regulatory

• 42 CFR 416.47, Condition for coverage: Medical records, via Cornell LII.
• Medicare Claims Processing Manual, Chapter 14: Ambulatory Surgical Centers, CMS (Rev. 13836, issued June 24, 2026). Section 40 on contractor pricing, and section 40.8 on devices furnished with no cost or with credit, effective July 1, 2026.
• Medicare Provider Compliance Tips: Ambulatory Surgical Centers, CMS Medicare Learning Network. The 2024 reporting period improper payment rate and its causes.
• Payment Policy for Ambulatory Surgery Center Services in the Facility, OWCP Medical Fee Schedule, U.S. Department of Labor. The implant billing and acquisition cost sections.
• Ill. Admin. Code tit. 50, section 9110.90, Illinois Workers’ Compensation Commission Medical Fee Schedule, via Cornell LII.
• 28 Tex. Admin. Code section 134.402, Ambulatory Surgical Center Fee Guideline, via Cornell LII. Subsection (g) on the certification of actual cost.

Payer reimbursement policies

• Device, Implant, and Skin Substitute Policy, Facility, UnitedHealthcare Commercial and Individual Exchange reimbursement policy 2026R5019F (version dated July 23, 2026).
• Implant, Device, and Tissue Policy, RP007, Blue Cross and Blue Shield of New Mexico (approved August 21, 2026, effective August 28, 2026).